Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor StrokeEleonora De Matteis, Giampietro Ruzza, Bruno Censori et al.|Stroke|2023Cited by 34
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study CohortRaffaele Ornello, Simone Beretta, Matteo Foschi et al.|Journal of the American Heart Association|2024Cited by 12
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Daniele Orsucci, Lucio D’Anna et al.|Stroke|2024Cited by 5
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attackFederico De Santis, Roberto Tarletti, Eleonora De Matteis et al.|Therapeutic Advances in Neurological Disorders|2025Cited by 1
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysisFederico De Santis, Roberto Tarletti, Raffaele Ornello et al.|Therapeutic Advances in Neurological Disorders|2025Cited by 0